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Abstract Mouse EC cell line ATDC5 undergoes differentiation
to form cartilage nodules via the cellular condensation stage in
the presence of insulin. ATDC5 cells expressed transcripts for
bone morphogenetic protein-4 (BMP-4), and type IA and type II
BMP receptors. Moreover, cells retained responsiveness to
BMP-4, which induced the formation of chondrocytes in the
culture. When transfected with a kinase domain-truncated type
IA BMP receptor construct, cells failed to undergo differentia-
tion beyond the condensation stage even in the presence of
insulin. The soluble form of type IA BMP receptor also blocked
the formation of chondrocytes in a dose dependent manner. These
lines of evidence suggested that autocrine BMP-4 signaling is
required for the conversion of chondrogenic precursor cells into
chondrocytes.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Mouse embryonal carcinoma-derived cell line ATDC5 pro-
vides an excellent in vitro model that exhibits the multistep
chondrogenic di¡erentiation observed during endochondral
bone formation [1]. In the presence of 5% fetal bovine serum
(FBS) and 10 Wg/ml insulin, ATDC5 cells di¡erentiate into
type II collagen-expressing chondrocytes (early-phase di¡er-
entiation) via the cellular condensation stage to form cartilage
nodules in culture [2]. After the growth and expansion of
cartilage nodules, hypertrophic chondrocytes appeared in as-
sociation with type X collagen gene expression and elevation
of alkaline phosphatase activity followed by matrix minerali-
zation (late-phase di¡erentiation) [1]. Thus, ATDC5 cells se-
quentially di¡erentiate to give rise to condensing prechondro-
cytes, type II collagen-expressing chondrocytes, type X
collagen-expressing hypertrophic chondrocytes and mineraliz-
ing chondrocytes in the presence of insulin or insulin-like
growth factor-I (IGF-I) without any additional growth/di¡er-
entiation factors [1,2].
It is intriguing to note that insulin or IGF-I ¢rst induces the
formation of regions of cellular condensation in which di¡er-
entiated chondrocytes appear [2]. Thus, numerous spotty nod-
ules of chondrocytes are formed in ATDC5 cell cultures in the
presence of insulin. Bone morphogenetic protein-2 (BMP-2),
however, induced the conversion of undi¡erentiated ATDC5
cells into chondrocytes (early-phase di¡erentiation) as well as
cellular hypertrophy and matrix mineralization (late-phase
di¡erentiation) [3]. Treatment with BMP-2 induced chondro-
genic conversion all over the culture of con£uent undi¡eren-
tiated cells to form a nearly continuous sheet of chondrocytes
even in the absence of insulin [3]. The stage of cellular con-
densation was skipped out in the cultures treated with exog-
enous BMP-2.
Here we report that autocrine BMP-4 signaling is required
for the conversion of prechondrocytes into chondrocytes in
the regions of cellular condensation during insulin-induced
di¡erentiation of ATDC5 cells by inhibiting autocrine BMP
signaling with the expression of dominant negative type IA
BMP receptor (BMPR-IA) or with treatment of cells with the
soluble form of BMPR-IA. However, the blockade of auto-
crine BMP signaling did not interfere with the induction of
cellular condensation.
2. Materials and methods
2.1. Materials
Recombinant human BMP-4 was purchased from R and D Systems
(Minneapolis, MN, USA) and diluted with phosphate-bu¡ered saline
(PBS) containing 0.1% bovine serum albumin (BSA; Sigma, St. Louis,
MO, USA).
2.2. Cell culture
ATDC5 cells were maintained in a 1:1 mixture of DME and Ham’s
F-12 (DME/F12) medium (Flow Laboratories, Irvine, UK) containing
5% FBS (JRH Biosciences, Lenexa, KS, USA), and ITS, i.e. 10 Wg/ml
bovine insulin (I; Boehringer Mannheim, Gaithersburg, MD, USA),
10 Wg/ml human transferrin (T; Boehringer Mannheim), and 3U1038
M sodium selenite (S; Sigma), as previously described [2]. The inoc-
ulum size of cells was 6U104 cells/well in six-multiwell plates (Corning
Glass, Corning, NY, USA) at 37‡C under 5% CO2 in air. On day 21,
the culture medium was switched to KMEM (Flow Laboratories)
containing 5% FBS plus ITS, and the CO2 concentration was shifted
to 3% for the facilitation of cellular hypertrophy and mineralization in
culture [1]. Balb/c 3T3 cells and C3H10T1/2 cells were plated in six-
multiwell plates at a density of 6U104 cells/well and cultured in DME
containing 10% FBS. MC3T3-E1 cells were plated in 6-multiwell
plates at a density of 6U104 cells/well and cultured in KMEM con-
taining 10% FBS. The medium was replaced every other day.
In some experiments, ATDC5 cells were plated at a density of
1U104 cells/well in 48-multiwell plates and cultured in DME/F12
medium containing 5% FBS and ITS. On day 3, the cultured medium
was replaced by DME/F12 medium containing 5% FBS, ITS and
soluble BMP type IA receptor (sBMPR) [4]. The medium was re-
placed every other day. On day 11, cells were ¢xed with 95% methanol
and stained with 0.1% Alcian blue 8GS (Fluka, Buchs, Switzerland) in
0.1 M HCl overnight.
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2.3. RNA extraction and hybridization analysis
Total RNA was prepared from the cultures by the single-step meth-
od of Chomczynski and Sacchi [5]. For Northern hybridization, 20 Wg
of total RNA was denatured with 6% formaldehyde, separated by 1%
agarose gel (SeaKem GTG, FMC Bioproducts, Rockland, ME, USA)
electrophoresis, and transferred onto Nytran membranes with Turbo-
blotter (Schleicher and Schuell, Dassel, Germany). Hybridization was
performed overnight at 42‡C with an appropriate cDNA probe (106
cpm/ml) in a solution containing 50% formamide, 6USSPE (0.9 M
NaCl, 20 mM NaH2PO4, 6 mM EDTA at pH 7.4), 0.1% BSA, 0.1%
Ficoll 400 (Pharmacia, Uppsala, Sweden), 0.1% polyvinylpyrolidone
(Wako Pure Chemical, Osaka, Japan), 0.1% SDS, and 200 Wg/ml
denatured salmon sperm DNA. Hybridization probes were prepared
by the random-primer method with a BcaBEST labeling kit (Takara,
Shiga, Japan) using the appropriate cDNA fragments: a 2.0 kb EcoRI
fragment of pKT1809 [6] as a probe for K1(I) collagen mRNA; a 1.4
kb EcoRI fragment of pKT1180 [6] as a probe for K1(II) collagen
mRNA, and a 2.2 kb EcoRI^XhoI fragment of pcDNA1R15B [7] as a
probe for PTH/PTHrP receptor mRNA. The following cDNA frag-
ments were ampli¢ed by reverse transcription-polymerase chain reac-
tion (RT-PCR) with a speci¢c primer set as described below, and used
as a probe for Northern hybridization: a 0.6 kb fragment of BMP-4
cDNA, a 0.34 kb fragment of BMP type IA receptor cDNA. After
hybridization, the ¢lters were washed for 30 min at 55‡C in 2USSPE
and 0.1% SDS, then washed for 30 min at 55‡C in 0.1USSPE, 0.1%
SDS, and then exposed to X-OMAT ¢lm (Eastman Kodak, Roches-
ter, NY, USA) at 380‡C with a Cronex lightening plus intensifying
screen (DuPont, Boston, MA, USA).
2.4. DNA transfection
For construction of the expression vector for the dominant-negative
mutant of mouse BMP type I A receptor (DN-BMPR-IA), a HindIII/
SacI fragment (670 bp) of pBvmBMPR [8] was subcloned into
pcDNA3 (Invitrogen, San Diego, CA, USA). The resultant expression
vector, pCMVvmBMPR, was transfected to undi¡erentiated ATDC5
cells by lipofection using Tfx-50 Reagent (Promega, Madison, WI,
USA). 2 days later, the cells were diluted 10-fold and incubated
with the medium containing 400 Wg/ml geneticin (GIBCO). After 10
days, six drug-resistant clones were selected and expanded. Cells from
each clone were plated in 12-multiwell plates at a density of 4U104
cells/well, and cultured in DME/F12 medium containing 5% FBS and
ITS for 15 days. Chondrogenic di¡erentiation of cells was examined
by Alcian blue staining [2].
2.5. RT-PCR
The RT-PCR was performed as described previously [2]. Brie£y,
¢rst-strand cDNA was synthesized using SuperScript II RNase H3
reverse transcriptase (GIBCO BRL, Gaithersburg, MD, USA) with
total RNA extracted from ATDC5 cells transfected with
pCMVvmBMPR. To detect the transgene, T3 (5P-TAATACGACT-
CACTATAGGG-3P) and SP6 (5P-GATTTAGGTGACACTATAG-
3P) primers (Invitrogen) were used. The PCR conditions were 94‡C
for 30 s, 55‡C for 1 min, 72‡C for 30 s for 32 cycles, and ¢nal
extension at 72‡C for 5 min.
3. Results
3.1. Expression of BMP-4, BMPR-IA, BMPR-II transcripts in
ATDC5 cells
The transcripts for the BMP-2 and BMP-4 genes are ex-
pressed spatially and temporally at the sites of skeletogenesis
such as limb buds and vertebrae during embryonic develop-
ment [9^11]. We studied the expression of BMP-4 mRNA in
several mouse mesenchymal cell lines by Northern blot anal-
ysis (Fig. 1A). Transcripts for the BMP-4 gene were not de-
tected in the Balb/c 3T3 cells, which are typical ¢broblastic
cells. However, the expression of BMP-4 mRNA was clearly
detected in a mesodermal progenitor cell line, C3H10T1/2,
which is capable of di¡erentiation into myoblasts, adipocytes
and chondrocytes [12]. The expression of the mRNA was also
readily detected in the con£uent monolayer culture (day 3) of
osteoblastic MC3T3-E1 cells isolated from mouse calvariae
(Fig. 1A) [13]. Thereafter, MC3T3-E1 cells gradually matured
after a prolonged culture as shown by the expression of PTH/
PTHrP receptor mRNA (day 14). The BMP-4 mRNA level
declined as the cells became mature on day 14 (Fig. 1A). The
mRNA level of BMP-4 gene is expressed at a relatively high
level in undi¡erentiated ATDC5 cells (Fig. 1A). In association
with the formation of cartilage nodules, the mRNA level of
BMP-4 gene slightly declined (Fig. 1A).
Two kinds of type I BMP receptors (BMPR-IA and
BMPR-IB) have been identi¢ed in vertebrates [14]. These
type I receptors bind BMP-2, BMP-4, and BMP-7 in combi-
nation with type II BMP receptor (BMPR-II) or type II acti-
vin receptor (ACTR-II). As shown in Fig. 1, ATDC5 cells
expressed two types of transcripts for BMPR-IA. The sizes
of these transcripts were identical to those found in mouse
tissues [15]. The level of these transcripts did not change sig-
ni¢cantly during di¡erentiation of ATDC5 cells (Fig. 1). The
expression of the receptor transcripts was also detected in
other osteoblastic and ¢broblastic cells including Balb/c 3T3
cells (Fig. 1A). Similarly, transcripts for the BMPR-II gene
were detected at all stages of di¡erentiation of ATDC5 cells.
The level of transcripts was upregulated during maturation of
di¡erentiated cells from day 10 to day 21 of culture (Fig. 1B).
The BMP-6 gene was expressed in parallel with the induction
of type II collagen and aggrecan mRNAs in di¡erentiated
ATDC5 cells, as previously reported [16]. However, we did
not detect transcripts for the BMP-2 or BMPR-IB genes in
ATDC5 cells (data not shown).
Fig. 1. Expressions of BMP-4, BMPR-IA, and BMPR-II transcripts
in mesenchymal cells. Cells were maintained as described in Section
2. Total RNA was prepared from Balb/c 3T3 cells on day 3,
C3H10T1/2 cells on day 3, MC3T3-E1 cells on day 3 and on day
14, and ATDC5 cells on the indicated days of culture. A: the same
membrane ¢lter was used for hybridization with the probes of
mouse BMP-4, mouse BMPR-IA, rat type II collagen, rat PTH/
PTHrP receptor, and rat type I collagen cDNAs. B: the same mem-
brane ¢lter was used for hybridization with the probes of mouse
BMPR-IA and BMPR-II cDNAs. The equivalent loading of RNA
(20 Wg/lane) was veri¢ed by ethidium bromide staining, as shown in
the bottom panels.
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3.2. Induction of early-phase di¡erentiation of ATDC5 cells by
BMP-4
Undi¡erentiated ATDC5 cells rapidly proliferate with a ¢-
broblastic morphology and ceased to grow at con£uence [2].
In the presence of 5% FCS and 10 Wg/ml insulin, cells give rise
to chondrocytes to form cartilage nodules via the cellular
condensation stage (early-phase di¡erentiation). Then hyper-
trophic chondrocytes appear in the cartilage nodule, and ma-
trix mineralization follows (late-phase di¡erentiation) [1].
When added in the culture, BMP-2 facilitated the progression
of early-phase and late-phase di¡erentiation of ATDC5 cells
[3]. Similarly, BMP-4 induced di¡erentiation to turn con£uent
undi¡erentiated cells into rounded chondrocytic cells all over
the culture (Fig. 2). The expression of type II collagen gene
was induced by the BMP-4 treatment (data not shown). Once
induction of early phase chondrogenic di¡erentiation of
ATDC5 cells occurred after transient exposure to BMP-4
Fig. 2. Stimulation of early-phase chondrogenic di¡erentiation of
ATDC5 cells by BMP-4. Cells were plated at a density of 4U104
cells per well in 12-multiwell plates, and grown to con£uence in
DME/F12 medium containing 5% FBS and ITS for 3 days. Cells
were then incubated in the absence (A) or presence of 200 ng/ml
BMP-4 (B) for additional 2 days. Bar, 200 Wm.
Fig. 3. Inhibition of early-phase chondrogenic di¡erentiation of
ATDC5 cells transfected with DN-BMPR-IA. Six ATDC5 clones
transfected with the dominant negative construct for BMPR-IA
were plated at a density of 4U104 cells per well in 12-multiwell
plates, and grown in DME/F12 medium containing 5% FBS and
ITS for 15 days. Phase-contrast micrographs of the mock-trans-
fected cells (A) and the DN-BMPR-IA transfected cells (B; clone
#3) are shown. B: arrows indicate the region of cellular condensa-
tion formed in the culture of the DN-BMPR-IA transfected cells.
Bars represent 200 Wm for (A) and (B). C: chondrogenic di¡erentia-
tion of cells was examined by Alcian blue staining on day 15.
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(48 h), cartilaginous phenotypes of ATDC5 cells were main-
tained without further administration of BMP-4 (data not
shown). Thus the culture plates were covered with a nearly
continuous sheet of chondrocytes within 2 days (Fig. 2B). In
contrast, cellular condensation took place at this time period
under the standard culture condition in the presence of insulin
without BMP-4 (Fig. 2A). The formation of condensing areas
topically regionalize chondrogenesis to occur, leading to the
subsequent appearance of spotty cartilage nodules within the
culture plates [2].
3.3. Inhibition of early-phase di¡erentiation of ATDC5 cells by
the expression of a kinase-truncated BMPR-IA or the
treatment with a soluble form of BMPR-IA
The truncated BMPR-IA without kinase domain have
shown to block BMP signaling e⁄ciently in vivo and in vitro
[17]. In order to block the BMPR-IA mediated signaling, we
transfected the dominant-negative construct of mouse BMPR-
IA (DN-BMPR-IA) into undi¡erentiated ATDC5 cells. Sev-
eral stable transfectants were cloned. We con¢rmed the ex-
pression of DN-BMPR-IA mRNA in each selected clone by
RT-PCR (data not shown). In the mock-transfected cells,
chondrocytes were di¡erentiated within the region of conden-
sation to result in the formation of cartilage nodules (Fig.
3A). Cartilage nodules were positively stained with Alcian
blue (Fig. 3C). In contrast, the formation of cartilage nodules
were evidently impaired in the DN-BMPR-IA-transfected cell
clones (Fig. 3B,C). However, it was clearly noted that the
formation of condensing areas was successfully induced even
in the DN-BMPR-IA-transfected clones (Fig. 3B).
Next, we attempted to block autocrine/paracrine BMP-4
signals due to the endogenous expression of BMP-4 in
ATDC5 cells by the treatment of cells with soluble BMPR-
IA (sBMPR) [4]. This soluble receptor was in monomer form
in solution and bound to BMP-4, but not to activin or trans-
forming growth factor-L1 [4]. When added in culture, sBMPR
is considered to bind to BMPs secreted into the culture me-
dium and to act as a antagonist by competing with wild mem-
brane-bound receptors. As shown in Fig. 4, sBMPR inhibited
chondrogenic di¡erentiation of ATDC5 cells in a dose depen-
dent manner (30^1000 ng/ml). Cellular condensation of
ATDC5 cells was not inhibited by the treatment with sBMPR.
4. Discussion
Endochondral bone formation begins with mesenchymal
condensation that de¢nes the regions of subsequent overt
chondrogenesis to occur. Thus mesenchymal condensation
pre¢gures the future con¢guration of skeletal elements in em-
bryo, leading to the formation of cartilaginous bone rudi-
ments. A number of BMP family members are expressed dur-
ing the early stages of chondrogenesis, including BMP-2,
BMP-4, BMP-5, BMP-7, and GDF-5 [9,11,18,19]. Transcripts
for the BMP-4 gene were clearly detected in chondrogenic
Fig. 4. Inhibitory e¡ect of sBMPR on early-phase chondrogenic dif-
ferentiation of ATDC5 cells. Cells were plated at a density of
1U104 cells per well in 48-multiwell plates, and maintained in
DME/F12 medium containing 5% FBS and ITS. On day 3, the cul-
ture medium was replaced by DME/F12 medium containing 5%
FBS, ITS and various concentrations of sBMPR. On day 11, we ex-
amined the formation of cartilage nodules in the control culture (A)
and the culture treated with 1000 ng/ml sBMPR (B) under a phase-
contrast microscope. B: the arrow indicates the region of cellular
condensation formed in the culture. Bars represent 200 Wm in A
and B. C: chondrogenic di¡erentiation of cells was examined by Al-
cian blue staining on day 11.
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ATDC5 cells as well as mesodermal progenitor C3H10T1/2
cells and osteoblastic MC3T3-E1 cells (Fig. 1A). But the ex-
pression of BMP-2 transcripts was not detected in ATDC5
cells. The cells expressed transcripts for BMPR-IA and
BMPR-II irrespective of di¡erentiation stages (Fig. 1), sug-
gesting that these BMPRs transmit chondrogenic actions of
endogenous and exogenous BMP-4 in ATDC5 cells (Fig. 2).
Upon transfection with the DN-BMPR construct, ATDC5
cells failed to di¡erentiate into chondrocytes (Fig. 3). Simi-
larly, sBMPR inhibited conversion of undi¡erentiated
ATDC5 cells into chondrocytes in a dose dependent manner
(Fig. 4). Formation of cartilage nodules was blocked by the
impairment of BMP-4 signaling, but condensing regions were
clearly established in the cultures (Figs. 3 and 4). These lines
of evidence suggested that autocrine BMP-4 signaling was
critically required for the conversion of condensing undi¡er-
entiated cells into chondrocytes. However, the impairment of
BMP signaling did not a¡ect cellular condensation that re-
gionalized the subsequent overt chondrogenesis. Only insulin
and/or IGF-I could induce cellular condensation of prechon-
drogenic cells [3]. In agreement with this observation, Roark
and Greer previously suggested that BMPs act only after the
condensation stage in chick limb bud micromass cultures [20].
When exposed to BMP-4 as well as BMP-2 prior to cellular
condensation at con£uence, undi¡erentiated ATDC5 cells in
culture evenly responded to them and were rapidly converted
to chondrocytes (Fig. 2) [3]. However, once condensed regions
were established in the cultures, cells in the inter-nodular
space (or outside the condensed regions) failed to respond
to the BMP stimuli. BMPs only facilitated the progressive
di¡erentiation of cells within condensed areas or cartilage
nodules. It is intriguing to address the question why cells in
the inter-nodular space failed to become chondrocytes in re-
sponse to BMP. Our collaborative study suggests that lateral
inhibition through Notch signaling play a role in this process
(K. Tezuka, submitted elsewhere). However, it is clear that the
process of cellular condensation and the conversion of pro-
genitor cells into chondrocytes is di¡erentially regulated by
the distinct signals. Autocrine BMP-4 signaling is critically
required for the latter process.
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